Therefore, if α-glucosidase inhibitors are effective to regulate blood glucose levels and insulin resistance, then much of the risk reduction can be explained by the combined effects of decreased blood glucose levels and increased insulin sensitivity [187]. This evidence concerns the gene INS and Insulin resistance.